相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statin use and risk of liver cancer: Evidence from two population-based studies
Kim Tu Tran et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh et al.
HEPATOLOGY (2020)
Statin Use is Protective Against Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease A Case-control Study
Margarita N. German et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)
Progress in low-field benchtop NMR spectroscopy in chemical and biochemical analysis
Martin Grootveld et al.
ANALYTICA CHIMICA ACTA (2019)
Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K/AKT signalling pathway
Taskeen Fathima Docrat et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
Gyuri Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Risk of hepatitis B virus reactivation in hepatitis B virus plus hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r plus dasabuvir plus ribavirin
C. M. Preda et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
Federica Iannelli et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2018)
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Anthony W. H. Chan et al.
JOURNAL OF HEPATOLOGY (2018)
Update in global trends and aetiology of hepatocellular carcinoma
Prashanth Rawla et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2018)
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study
Gyuri Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Atorvastatin Decreases HBx-Induced Phospho-Akt in Hepatocytes via P2X Receptors
Aram Ghalali et al.
MOLECULAR CANCER RESEARCH (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hepatic stellate cells as key target in liver fibrosis
Takaaki Higashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Statin use and risk of cancer: An overview of meta-analyses
Krishna Undela et al.
WORLD JOURNAL OF META-ANALYSIS (2017)
Atorvastatin and Fluvastatin Are Associated With Dose-Dependent Reductions in Cirrhosis and Hepatocellular Carcinoma, Among Patients With Hepatitis C Virus: Results From ERCHIVES
Tracey G. Simon et al.
HEPATOLOGY (2016)
Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
Yao-Yao Zhou et al.
ONCOTARGET (2016)
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
Lee-Won Chong et al.
BMC GASTROENTEROLOGY (2015)
The Safety and Benefit of Statins in Liver Cirrhosis: a Review
K. Souk et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2015)
Statin use and non-alcoholic steatohepatitis in at risk individuals
Paola Dongiovanni et al.
JOURNAL OF HEPATOLOGY (2015)
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Tracey G. Simon et al.
JOURNAL OF HEPATOLOGY (2015)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
Yao-Hsu Yang et al.
JOURNAL OF HEPATOLOGY (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Cancer Risk in HBV Patients With Statin and Metformin Use A Population-Based Cohort Study
Chang-I. Chen et al.
MEDICINE (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin use and risk of hepatocellular carcinoma in a US population
Katherine A. McGlynn et al.
CANCER EPIDEMIOLOGY (2014)
Statins in oncological research: From experimental studies to clinical practice
Peter Kubatka et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Statin treatment reduces the risk of hepatocellular carcinoma but not colon cancer-results from a nationwide case-control study in Sweden
Linda Bjorkhem-Bergman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2014)
Statin use and risk of liver cancer: an update meta-analysis
Meng Shi et al.
BMJ OPEN (2014)
Common cancer risk and statins: a population-based case-control study in a Chinese population
Henry W. C. Leung et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Prediction models of long-term Cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles
Mei-Hsuan Lee et al.
HEPATOLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Patrizia Gazzerro et al.
PHARMACOLOGICAL REVIEWS (2012)
Statin Use and the Risk of Liver Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Zhongwei Cao et al.
CANCER RESEARCH (2011)
Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
Borna Relja et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Statins and Risk of Cancer A Retrospective Cohort Analysis of 45,857 Matched Pairs From an Electronic Medical Records Database of 11 Million Adult Americans
Claudio Marelli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan
Yasuyuki Matsushita et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma
Joan Montero et al.
CANCER RESEARCH (2008)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Pravastatin use and the five-year incidence of cancer in coronary heart disease patients: from the prevention of coronary sclerosis study
Shinichi Sato et al.
JOURNAL OF EPIDEMIOLOGY (2006)
Anti-inflammatory effect of pitavastatin on NF-κB activated by TNF-α in hepatocellular carcinoma cells
J Wang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study
JA Davila et al.
GUT (2005)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma
JI Herrero et al.
LIVER TRANSPLANTATION (2001)
Statins as a newly recognized type of immunomodulator
B Kwak et al.
NATURE MEDICINE (2000)
分享论文
